Clinical Trial Update: Effect of Tributyrin Supplementation on Glycemic Control, Inflammation, and Cardiovascular Risk in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluates whether tributyrin supplementation improves glycemic control, inflammation, and cardiovascular risk in adults with type 2 diabetes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tributyrin (tributyrin)

Snippet

Sponsor: Ain Shams University | Conditions: Diabete Mellitus | Phase 3 | Status: NOT_YET_RECRUITING